Publications

Below is a list of publications that cover PA's expertise in life sciences.  These range from R&D effectiveness and supply chain improvement  through to collaboration and commercialization of IP.

	A better approach to global change control for pharmaceutical companies
	A new model for biotech - do biotechs need a new business model?
	Advancing medicine distribution now
	Aiming high in the NHS - Achieving breakthrough performance
	AMFA, Affordable Medicines for Africa
	An African solution to an African problem - PA supporting Affordable Medicines for Africa
	An innovative diagnosis
	Applying genomic technologies in clinical diagnostics
	Automatic injection devices : developments and future trends
	Board Development Partnership - PA Consulting Group-led consortium supporting PCT Boards
	Burden of diabetes demands integrated approaches to innovation: next-generation tools
	Combined efforts - realizing the potential of combination products
	Compliance and effectiveness - two sides of the marketing coin
	Cost reduction in medical devices throughout their life cycle
	Creating winning pharmaceutical partnerships in the 21st century
	CRM - PA's survey on CRM in the pharmaceutical industry (2000)
	Delivering a patient-centred NHS - summary of a survey of Chief Executives in the UK National Health Service
	Don't stop the runaway train - harness its energy to improve the odds of making a medical breakthrough
	Drug device combination products
	E-business in pharma survey - PA finds e-business is business as usual
	Effective delivery of new healthcare products and services
	Effective portfolio management - outlining the key elements of an effective portfolio management program
	European pharmaceutical pricing - optimising launch sequence to maximise product value
	Fast incremental supply chain improvement for the health sector
	Gaining competitive advantage for a US sales organisation
	Global pharmaceutical company - Delivering enhanced value in a cost constrained and regulated environment
	Growth opportunities for medium pharma firms
	Health information exchange USA
	Human vision models slash development time for new contact lens technologies
	Impacts 14: Supply chain management and outsourcing
	Impacts 13: Bringing new drugs to market - at last
	Impacts Autumn 2004
	Impacts Autumn 2005
	Impacts March 2006, Perspectives on healthcare
	Impacts March 2007
	Impacts September 2006
	Impacts Spring 2005
	Impacts Winter 2003
	Impacts Winter 2005
	Impacts, March 2006: Patient directed healthcare
	Impacts, March 2006: Implementing risk-based programme management
	Impacts, March 2006: Interview with Gary Noon, Aegate's new CEO
	Impacts, March 2006: Meeting the threat of an avian flu pandemic - how simulation models point to bold action
	Impacts, March 2006: When two heads are better than one: the role of the COO R&D
	Improving discovery by learning to make better decisions - PA's ARBITER approach
	Joined up thinking - realising the benefits of scale from M&As in pharma
	Learning to improve the decision making process in research
	Leveraging compliance to accelerate programs
	Manufacturing compliance - an emerging topic in life science companies' boardrooms
	Mass serialisation
	Mid-sized pharma health check
	Operational effectiveness - achieving greater efficiency and effectiveness in R&D operations
	Parenteral delivery is here to stay
	PA's consulting services to life science companies
	PA's track record in the development of specialised injection systems
	Pharma sales training in a customer-centric world
	Portfolio management seminar - executive summary
	Prescription for collaboration - an in-depth discussion of the issues surrounding pharmaceutical collaborations
	Proactive compliance in pharmaceuticals marketing
	Putting the customer first
	Putting the customer first: new models for pharmaceutical selling
	Radically accelerating R&D to combat a biothreat
	Reducing NHS Orthopaedic waiting lists
	Risk in the pharmaceutical supply chain – for suppliers and consumers
	Shared services, delivering the promise
	Simulating an Avian Flu pandemic
	Sourcing for business success in the pharmaceutical industry
	Sourcing Why Gamble
	Statement of interest - delivering value from new technologies
	Strategies to improve R&D productivity
	The big squeeze - the pharmaceutical industry needs radical change if it is to preserve its postion and ultimately thrive
	The future for parenteral delivery - the answer is to develop better, more advanced auto-injectors
	The Genome Effect Breakout 5
	The independent sector is key to the long term survival of the NHS
	The new building blocks for blockbusters - single drugs for single indications are hard to find
	The strategic impact of transaction costs
	Thin client medical devices
	What will the healthcare supply chain look like in 2015?
	Wireless systems in healthcare